Another study indicated that bergenin and its analogs have an inhibitory effect on BACE1 and hence may be useful in Alzheimer’s disease (Kashima and Miyazawa, 2013). The gene discussed is BACE1; the disease is early-onset autosomal dominant Alzheimer disease.